Skip to main content

Health Minister Rona Ambrose speaks in Calgary on Aug. 19, 2013.

CHRIS BOLIN/The Globe and Mail

Health Minister Rona Ambrose is suggesting there might soon be movement from Canada following pleas from the United States to outlaw addictive, generic forms of the highly prescribed painkiller OxyContin.

Ambrose says she's been "examining" the issue and that the government intends to move forward soon with a prescription drug strategy.

In 2010, Canada inched past the United States to become the highest opioid-consuming country on the planet on a per-capita basis.

Story continues below advertisement

Nonetheless, U.S. appeals to Canada to ban addictive formulations of the drug were rebuffed by Ambrose's predecessor, Leona Aglukkaq, who said it was a provincial matter.

Some provinces, like Ontario and B.C., only cover prescriptions for the new tamper-resistant alternative, OxyNEO, but usually only for senior citizens on social assistance.

The provinces have no control over what private health insurers will pay for, and late last year, Health Canada gave six drug companies the green light to begin manufacturing the generic forms of the drug.

As many Ontario residents now die from opioid overdoses as they do in car accidents, according to a recent study by KFLA Public Health, based in Kingston, Ont.

Report an error
Comments

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • All comments will be reviewed by one or more moderators before being posted to the site. This should only take a few moments.
  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed. Commenters who repeatedly violate community guidelines may be suspended, causing them to temporarily lose their ability to engage with comments.

Read our community guidelines here

Discussion loading ...

Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.
Cannabis pro newsletter